Funds and ETFs Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Healthcare Facilities & Services

Market Closed - Nyse 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
9 USD -1.42% Intraday chart for Cryo-Cell International, Inc. +1.12% +56.52%
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9 USD
Average target price
9 USD
Spread / Average Target
0.00%
Consensus
  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Funds and ETFs Cryo-Cell International, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW